Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
Emilia Montagna, Giuseppe Cancello, Vincenzo Bagnardi, Davide Pastrello, Silvia Dellapasqua, Gino Perri, Giuseppe Viale, Paolo Veronesi, Alberto Luini, Mattia Intra, Angelica Calleri, Cristiano RampinVolume:
12
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.clbc.2012.03.008
File:
PDF, 488 KB
english, 2012